Felix Theeuwes

2012

In 2012, Felix Theeuwes earned a total compensation of $481K as Chairman and Chief Scientific Officer at DURECT, a 51% decrease compared to previous year.

Compensation breakdown

Option Awards$196,032
Salary$269,005
Other$15,943
Total$480,979

Theeuwes received $269K in salary, accounting for 56% of the total pay in 2012.

Theeuwes also received $196K in option awards and $15.9K in other compensation.

Rankings

In 2012, Felix Theeuwes' compensation ranked 8,875th out of 11,487 executives tracked by ExecPay. In other words, Theeuwes earned more than 22.7% of executives.

ClassificationRankingPercentile
All
8,875
out of 11,487
23rd
Division
Manufacturing
3,237
out of 4,253
24th
Major group
Chemicals And Allied Products
873
out of 1,198
27th
Industry group
Drugs
642
out of 920
30th
Industry
Pharmaceutical Preparations
498
out of 700
29th
Source: SEC filing on April 22, 2015.

Theeuwes' colleagues

We found four more compensation records of executives who worked with Felix Theeuwes at DURECT in 2012.

2012

James Brown

DURECT

Chief Executive Officer

2012

Su Yum

DURECT

Executive Vice President, Pharmaceutical Systems R&D

2012

Matthew Hogan

DURECT

Chief Financial Officer

2012

Judy Joice

DURECT

Senior Vice President, Operations and Corporate Quality Assurance

News

You may also like